Fourteen heart-attack tests were still listed as unfixed
The US Food and Drug Administration lists, by manufacturer, cleared troponin devices whose makers had not addressed biotin interference. Fourteen are on it.
What the study found
The FDA names 14 troponin devices that had not fixed the problem
The US Food and Drug Administration listed, by manufacturer and clearance number, the cleared devices for troponin, the blood marker of heart damage, whose makers had not addressed biotin interference. Fourteen of them. That counts the ones that had not, not the many that had.
The caveat · No size given for any device's error
The table names devices the agency judged had not addressed the risk, and puts no number on the size of the error on any of them. Several entries are point-of-care strip tests rather than the laboratory analysers most hospitals run, and some clearances date to the 1990s. The page carries no version marker, so the count of fourteen is a snapshot of one day in September 2026.